BlackRock, Inc. 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Purchase |
2025-03-31 | 13G | Sutro Biopharma, Inc. STRO |
BLACKROCK INC BLK |
6,143,608 7.300% |
319,686 (+5.49%) |
Filing |
| 2024-01-24 5:23 pm Purchase |
2023-12-31 | 13G | Sutro Biopharma, Inc. STRO |
BLACKROCK INC BLK |
5,823,922 9.600% |
963,782 (+19.83%) |
Filing |
| 2023-02-07 2:55 pm Purchase |
2022-12-31 | 13G | Sutro Biopharma, Inc. STRO |
BLACKROCK INC BLK |
4,860,140 8.500% |
1,160,097 (+31.35%) |
Filing |
| 2022-02-02 7:18 pm Purchase |
2021-12-31 | 13G | Sutro Biopharma, Inc. STRO |
BLACKROCK INC BLK |
3,700,043 8.000% |
982,114 (+36.13%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
BLACKROCK INC BLK |
2,717,929 6.200% |
2,717,929 (New Position) |
Filing |